urlscan.io logo urlscan.io
SecurityTrails logo

aptevotherapeutics.com Open in urlscan Pro
23.254.131.60  Public Scan

Back to summary
Submitted URL: https://usw2.nyl.as/t1/275/ajus5fg8e1gq97q696leuudvo/3/dafa0725f65dc889f820e0d89d5a86eeebe0eb7788004dfaa39107089614e538
Effective URL: https://aptevotherapeutics.com/
Submission: On November 27 via api from BE — Scanned from DE

Form analysis 1 forms found in the DOM

GET https://aptevotherapeutics.com/

<form role="search" id="searchform" action="https://aptevotherapeutics.com/" class="qode_search_form" method="get">
  <div class="container">
    <div class="container_inner clearfix">
      <i class="qode_icon_font_awesome fa fa-search qode_icon_in_search"></i> <input type="text" placeholder="Search" name="s" class="qode_search_field" autocomplete="off">
      <input type="submit" value="Search">
      <div class="qode_search_close">
        <a href="#">
                    <i class="qode_icon_font_awesome fa fa-times qode_icon_in_search"></i>                </a>
      </div>
    </div>
  </div>
</form>

Text Content

 * About Us
    * Management Team
    * Board of Directors

 * Technology
    * ADAPTIR
    * ADAPTIR-FLEX

 * Pipeline
    * APVO436
    * ALG.APV-527
    * APVO603
    * APVO442
    * APVO711

 * Investors
    * Stock Details
    * News
    * Events
    * Presentations
    * Financial Reports
    * Corporate Governance
    * Investor FAQ
    * Investor Contacts

 * Contact / Careers

 * About Us
   * Management Team
   * Board of Directors
 * Technology
   * ADAPTIR
   * ADAPTIR-FLEX
 * Pipeline
   * APVO436
   * ALG.APV-527
   * APVO603
   * APVO442
   * APVO711
 * Investors
   * Stock Details
   * News
   * Events
   * Presentations
   * Financial Reports
   * Corporate Governance
   * Investor FAQ
   * Investor Contacts
 * Contact / Careers


ADVANCING THE SCIENCE OF IMMUNO-ONCOLOGY



BROAD PIPELINE DESIGNED WITH MULTIPLE MECHANISMS OF ACTION




LEAD CANDIDATE APVO436: IN THE FIGHT AGAINST ACUTE MYELOID LEUKEMIA




LEARN MORE


WHY APTEVO: VIEW THE CORPORATE PRESENTATION




LEARN MORE


MEETING MILESTONES:  LATEST NEWS & ACCOMPLISHMENTS




LEARN MORE


APTEVO: DEVELOPING MEANINGFUL THERAPEUTICS THAT PRODUCE PROMISING OUTCOMES IN
THE FIGHT AGAINST CANCER

Aptevo Therapeutics Inc. is a clinical-stage biotechnology company focused on
developing novel bispecific immunotherapies for the treatment of cancer. Aptevo
is seeking to improve treatment outcomes and transform the lives of cancer
patients.




About Us
Our Technology

Pipeline
Investors

Contact / Careers
Privacy Policy

Terms of Use
Aptevo Terms and Conditions

Copyright 2023 | Aptevo Therapeutics




Notifications